Tech Company Financing Transactions
ASLAN Pharmaceuticals Funding Round
ASLAN Pharmaceuticals, based in Singapore, secured $34 million from Temasek Holdings, Morningside Group and Sagamore Ventures.
Transaction Overview
Company Name
Announced On
12/8/2015
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series C
Investors
Proceeds Purpose
ASLAN plans to use the proceeds to further accelerate clinical development of its pipeline of four novel therapeutic agents that have the potential to treat tumour types highly prevalent in Asia.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
83 Clemenceau Ave. UE Sq. 12-03
Singapore, 239920
Singapore
Singapore, 239920
Singapore
Phone
Website
Email Address
Overview
ASLAN Pharmaceuticals is engaged in the production of novel drugs for the global healthcare market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carl Firth
Chief Medical Officer
Chih-Yi Hsieh
VP - Bus. Development
Stephen Doyle
VP - Bus. Development
Mark McHale
VP - Finance
Kiran Asarpota
Browse more venture capital transactions:
Prev: 12/8/2015: IncomeAnd venture capital transaction
Next: 12/8/2015: NowThis venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs